心力衰竭合并糖尿病患者心脏再同步化治疗疗效的研究进展

Research Progress on the Efficacy of Cardiac Resynchronization Therapy in Patients with Heart Failure and Diabetes Mellitus

心脏再同步化治疗(CRT)是针对伴有心脏非同步收缩的心力衰竭患者的有效治疗方法,其疗效受多种临床因素影响。本文围绕糖尿病这一常见危险因素及临床合并症进行分析,叙述了合并糖尿病对心力衰竭患者CRT植入术后预后的影响,并简述了心力衰竭合并糖尿病患者不良预后的预测因素以及改善该部分患者CRT植入术后预后的措施,以期为合并糖尿病的心力衰竭患者CRT植入术前筛选及术后综合治疗提供参考。

Cardiac resynchronization therapy(CRT)is an effective treatment method for patients with heart failure(HF)accompanied by unsynchronized cardiac contractions,and its efficacy is affected by a variety of clinical factors.This article discusses the influence of diabetes,a common risk factor and clinical complication,on the prognosis of HF patients after CRT implantation,and briefly describes the predictors of poor prognosis of patients with HF and diabetes and the measures to improve the prognosis of these patients after CRT implantation,in order to provide reference for preoperative screening and postoperative comprehensive treatment of CRT implantation in patients with HF and diabetes.